| Dr Wei Phin Tan, MD | |
|
222 E 41st St Fl 12, New York, NY 10017-6739 | |
| (646) 825-6300 | |
| Not Available |
| Full Name | Dr Wei Phin Tan |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 11 Years |
| Location | 222 E 41st St Fl 12, New York, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083057384 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 282N00000X (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vns Of Ny Home Care Chha | New york, NY | Home health agency |
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
The Associated Press reports that Ugandan President Yoweri Museveni has said that the anti-gay bill to be considered late next month or early March by the country's parliament "is too harsh and [he] has encouraged his ruling National Resistance Movement Party to overturn the death sentence provision. Several lawmakers have agreed and say they will push to remove the statute."
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces final positive results of its pivotal phase III clinical study in immunocompetent patients with recurrent herpes labialis (LIP Study) treated with acyclovir Lauriad®. Primary and secondary endpoints have been met with marked efficacy and good tolerance.
The Company's net loss for the quarter ended October 31, 2009 amounted to $2.5 million or ($0.01) per share, compared to $10.9 million or ($0.04) per share, for the quarter ended October 31, 2008.
Scientists from various Australian universities in collaboration with the University of Barcelona have compared the effects of mobile use while driving with the effects of alcohol using a simulation.
› Verified 8 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
The Associated Press reports that Ugandan President Yoweri Museveni has said that the anti-gay bill to be considered late next month or early March by the country's parliament "is too harsh and [he] has encouraged his ruling National Resistance Movement Party to overturn the death sentence provision. Several lawmakers have agreed and say they will push to remove the statute."
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces final positive results of its pivotal phase III clinical study in immunocompetent patients with recurrent herpes labialis (LIP Study) treated with acyclovir Lauriad®. Primary and secondary endpoints have been met with marked efficacy and good tolerance.
The Company's net loss for the quarter ended October 31, 2009 amounted to $2.5 million or ($0.01) per share, compared to $10.9 million or ($0.04) per share, for the quarter ended October 31, 2008.
Scientists from various Australian universities in collaboration with the University of Barcelona have compared the effects of mobile use while driving with the effects of alcohol using a simulation.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wei Phin Tan, MD 1 Federal St Ste Sw200, Camden, NJ 08103-1155 Ph: (856) 356-4924 | Dr Wei Phin Tan, MD 222 E 41st St Fl 12, New York, NY 10017-6739 Ph: (646) 825-6300 |
News Archive
The Associated Press reports that Ugandan President Yoweri Museveni has said that the anti-gay bill to be considered late next month or early March by the country's parliament "is too harsh and [he] has encouraged his ruling National Resistance Movement Party to overturn the death sentence provision. Several lawmakers have agreed and say they will push to remove the statute."
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces final positive results of its pivotal phase III clinical study in immunocompetent patients with recurrent herpes labialis (LIP Study) treated with acyclovir Lauriad®. Primary and secondary endpoints have been met with marked efficacy and good tolerance.
The Company's net loss for the quarter ended October 31, 2009 amounted to $2.5 million or ($0.01) per share, compared to $10.9 million or ($0.04) per share, for the quarter ended October 31, 2008.
Scientists from various Australian universities in collaboration with the University of Barcelona have compared the effects of mobile use while driving with the effects of alcohol using a simulation.
› Verified 8 days ago
Dr. Reza Mehrazin, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Gustave L Levy Pl # 1272, Mount Sinai School Of Medicine / Urology Dept, New York, NY 10029 Phone: 212-241-4812 Fax: 212-987-4675 | |
Dr. Joseph Paul Alukal, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 150 E 32nd St, 2nd Floor, New York, NY 10016 Phone: 646-825-6300 Fax: 646-825-6399 | |
Dr. Lamont Jordan Barlow, Urology Medicare: Medicare Enrolled Practice Location: 423 E 23rd St, New York, NY 10010 Phone: 212-686-7500 | |
Matthew Katz, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 222 E 41st St, New York, NY 10017 Phone: 646-825-6300 | |
Dr. Victor Allon Mcpherson, MD, MSC Urology Medicare: Not Enrolled in Medicare Practice Location: 1275 York Ave, New York, NY 10065 Phone: 551-444-8672 | |
Mark Thomas Dawidek, Urology Medicare: Not Enrolled in Medicare Practice Location: 303 E 60th St Apt 32g, New York, NY 10022 Phone: 236-989-9955 | |
David M Weiner, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 161 Fort Washington Ave, 11th Floor, New York, NY 10032 Phone: 212-305-0114 Fax: 212-305-0129 |